5 Werkstofftechnik
Filtern
Dokumenttyp
Sprache
- Englisch (2)
Referierte Publikation
- ja (2)
Schlagworte
- Bone regeneration (2) (entfernen)
Organisationseinheit der BAM
Tricalcium phosphate (b-TCP) can be used as bone graft, exhibiting suitable bioabsorption and osteoconduction properties. The presence of silica may induce the formation of a hydroxyapatite layer, enhancing the integration between implant and bone tissue. Preceramic polymers present silicon in their composition, being a source of SiO2 after thermal treatment. Using the versatility of 3D printing, b-TCP and a polysiloxane were combined to manufacture a bulkb-TCP with a silica coating. For the additive manufacturing process, PMMA powder was used as passive binder for the b-TCP particles, and polymethylsilsesquioxane (MK), dissolved in an organic solvent, was used both as a printing binder (ink) and as the source of SiO2 for the coating. Five distinct coating compositions were printed with increasing amounts of MK. The structures were then submitted to heat treatment at 1180 °C for 4 h. XRD and FTIR showed no chemical reaction between the calcium phosphate and silica. SEM allowed observation of a silicon-based ating on the structure surface. Mechanical strength of the sintered porous structures was within the range of that of trabecular bones.
(1) Background: The desire to avoid autograft harvesting in implant dentistry has prompted an ever-increasing quest for bioceramic bone substitutes, which stimulate osteogenesis while resorbing in a timely fashion. Consequently, a highly bioactive silicon containing calcium alkali orthophosphate (Si-CAP) material was created, which previously was shown to induce greater bone cell maturation and bone neo-formation than β-tricalcium phosphate (β-TCP) in vivo as well as in vitro. Our study tested the hypothesis that the enhanced effect on bone cell function in vitro and in sheep in vivo would lead to more copious bone neoformation in patients following sinus floor augmentation (SFA) employing Si-CAP when compared to β-TCP. (2) Methods: The effects of Si-CAP on osteogenesis and Si-CAP resorbability were evaluated in biopsies harvested from 38 patients six months after SFA in comparison to β-TCP employing undecalcified histology, histomorphometry, and immunohistochemical analysis of osteogenic marker expression. (3) Results: Si-CAP as well as β-TCP supported matrix mineralization and bone formation. Apically furthest away from the original bone tissue, Si-CAP induced significantly higher bone formation, bone-bonding (bone-bioceramic contact), and granule resorption than β-TCP. This was in conjunction with a higher expression of osteogenic markers. (4) Conclusions: Si-CAP induced higher and more advanced bone formation and resorbability than β-TCP, while β-TCP’s remarkable osteoconductivity has been widely demonstrated. Hence, Si-CAP constitutes a well-suited bioactive graft choice for SFA in the clinical arena.